Full Text
PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate- A Pharmacovigilance Analysis of the Adverse Event Reporting System

Abstract

Authors

A.K. Ali

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×